MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This Week Last Year in Medtech: March 26 – April 1

Article-This Week Last Year in Medtech: March 26 – April 1

Archive Holdings Inc. / The Image Bank via Getty Images calendar pages
See what ActiGraft, Embecta, and VNS were up to this time last year.

VNS Makes an Impact in Costs for Children with Epilepsy

The study was from Ann & Robert H. Lurie Children's Hospital of Chicago and published in the journal Epilepsia.

Lessons from the Evolution of the Automated External Defibrillator

Researchers credit rapid prototyping and user-centric design key to developing the small, light, and portable automated external defibrillator.

Novel Wound Care Systems Shipped to Ukraine

ActiGraft blood-clotting wound care systems were developed to treat trauma and other injuries.

Some Diagnostics Companies Can Breathe a Sigh of Relief

Companies that sell 510(K) cleared diagnostic products in the United States may have a head start on meeting the EU Commission's new IVDR requirements.

Poland Gets Its First Robotic Electrophysiology Program

Poland’s National Institute of Cardiology has established the first robotic electrophysiology program in the country with a Stereotaxis system.

Embecta Is the New/Old Kid on the Block in Diabetes

Embecta’s CEO Devdatt Kurdikar joins us for this episode of Let’s Talk Medtech, to discuss being spun out from Becton Dickinson and how its rich history gives it an advantage in the diabetes market.

Could Vagal Nerve Stim Reduce Post-Op Afib?

New findings from the Feinstein Institutes for Medical Research could lead to better options to avoid arrythmias that can arise after cardiac surgery.

TAGS: News
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.